Sequential Changes of NLRP3 Inflammasome Activation in Sepsis and its Relationship With Death-Reference-Cited by-同舟云学术

Sequential Changes of NLRP3 Inflammasome Activation in Sepsis and its Relationship With Death

Published:2020-02-11 Issue:3 Volume:54 Page:294-300
ISSN:1073-2322
Container-title:Shock
language:en
Short-container-title:

Author:

Garnacho-Montero José,Palacios-García Inmaculada,Díaz-Martín Ana,Gutiérrez-Pizarraya Antonio,López-Sánchez José M.,Gómez Elísabet Alcocer,Cordero Mario D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine

Reference24 articles.

1. Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases;Rello;Clin Microbiol Infect,2018

2. Activation and regulation of the inflammasomes;Latz;Nat Rev Immunol,2013

3. Stress-induced NLRP3 inflammasome in human diseases;Alcocer-Gómez;Adv Protein Chem Struct Biol,2017

4. The understanding and management of organism toxicity in septic shock;Genga;J Innate Immun,2018

5. Immunosuppression in patients who die of sepsis and multiple organ failure;Boomer;JAMA,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell death proteins in sepsis: key players and modern therapeutic approaches;Frontiers in Immunology;2024-01-11

2. 25-hydroxycholesterol aggravates oxygen-glucose deprivation/reoxygenation-induced pyroptosis through promoting activation of NLRP3 inflammasome in H9C2 cardiomyocytes;Brazilian Journal of Medical and Biological Research;2024

3. Prognostic value of inflammatory cytokine detection for sepsis patients in ICU: a meta-analysis;American Journal of Translational Research;2024

4. Persistent NLRP3 inflammasome activation is associated with delayed immunosuppression in septic patients;Journal of Leukocyte Biology;2023-12-26

5. GBP2 upregulated in LPS-stimulated macrophages-derived exosomes accelerates septic lung injury by activating epithelial cell NLRP3 signaling;International Immunopharmacology;2023-11